Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biogen, Inc. (NQ: BIIB )

277.26 USD UNCHANGED
Streaming Delayed Price Updated: 7:57 PM EST, Feb 25, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Biogen, Inc.

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
The Partnership, Inc. Launches New North Carolina Mid-Career Leadership Accelerator Program
Tags Skills Development Economic Growth NASDAQ:BIIB
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Life Science Cares and Biogen Foundation Help Launch Food For Free’s Just Eats Program
From GlobeNewswire News Releases
Life Sciences Cares & Biogen Foundation Help Launch Food for Free's Just Eats Program
Tags Just Eats Grocery Box NASDAQ:BIIB Partnerships
From 3BL Media: Corporate Social Responsibility, Energy and Health News
2 Best Pharma Stocks to Buy Right Now
These under-appreciated pharma stocks have the potential to become long-term winners. 
Tags REGN BIIB AMGN
From Motley Fool
Where Will Biogen Be in 5 Years?
The biotech has a lot riding on whether the FDA approves its potential Alzheimer's treatment, aducanumab. 
Tags BIIB Market News ESALF
From Motley Fool
Should Investors Worry About Moderna's Vaccine Delays?
The short answer: No. 
Tags BIIB Market News MRNA
From Motley Fool
What Are the Long-Term Prospects for Moderna?
The biotech's messenger RNA platform is promising. But some investors could have qualms about its current valuation. 
Tags MRNA PFE REGN
From Motley Fool
Will Editas Medicine's CEO Change Help or Hurt?
Turnover at the top of a company can be troubling. But it can sometimes be a good thing. 
Tags NTLA Market News BIIB
From Motley Fool
Is Biogen Stock a Buy?
Investors have been riding a roller coaster over the past year. 
Tags XLV SAGE BIIB
From Motley Fool
lululemon athletica Larger Than S&P 500 Component Biogen
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component lululemon athletica inc (LULU) was identified as having a larger market cap than the smaller end of the S&P... 
Tags Stocks
From Market News Video
Here's What Caused Royalty Pharma's Mixed Results in Q4
The company's royalties revenue soared, but its earnings sank. 
Tags VRTX JNJ MRK
From Motley Fool
22 additional dividend stocks that Warren Buffett might consider buying
His Berkshire Hathaway conglomerate recently started buying shares of Verizon and Chevron --- both have attractive dividend yields well-supported by expected cash flow. 
Tags KMI PFE WMB
From MarketWatch
14 AI Stocks to Stay Away From
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>Whether in transportation, manufacturing or healthcare, don't touch any... 
Tags ATEX XRX LUV
From InvestorPlace
Cassava Stock Pops Again; Can It Take On Biogen In Alzheimer's Drugs?
Cassava Sciences is part of a shift in Alzheimer's treatment, an analyst said Tuesday as he boosted his price target on SAVA stock. Shares of the leading Alzheimer's stock popped again. 
From Investor's Business Daily
Notable Insider Buys: Biotech IPOs, Curiositystream, Greenbrier And More
Conventional wisdom says that insiders and 10% owners really only buy shares of a company for one reason, they believe the stock price will rise and they want to profit from it. So insider buying can... 
Tags Stocks / Equities Services Healthcare
From Blogs - TalkMarkets
The Past Week's Notable Insider Buys: Biotech IPOs, Curiositystream, Greenbrier And More
Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty. Some insiders have ... 
Tags LABP Lucira Health ANTM
From Benzinga
TE Connectivity Takes Over #161 Spot From Biogen
In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, TE Connectivity Ltd (TEL) has taken over the #161 spot from Biogen Inc (BIIB), according to The... 
Tags Stocks
From Market News Video
Looking For Biotech Stocks To Buy Now? 4 Names To Know
Tags Market News
From Stockmarket.com
Is the FDA Delay Actually Good News for Biogen's Alzheimer's Drug?
The lack of a quick rejection could be a good sign for the drug's prospects. 
Tags ESALY Market News BIIB
From Motley Fool
Why Is Everyone Talking About Biogen Stock?
A make it or break it regulatory decision is on the horizon. 
Tags SAGE Market News BIIB
From Motley Fool
Why Alkermes' Q4 Results Were Better Than They Might Seem
The biotech posted a big year-over-year sales decline. But there was a good reason for it. 
Tags ALKS Market News BIIB
From Motley Fool
ACIU Stock: Why AC Immune Shares Are Rocketing Higher Today
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>Swiss biopharma AC Immune has released positive updates this week on both... 
Tags Today's Market BIIB Market News
From InvestorPlace
Alzheimer's Vaccine Prods AC Immune Stock To A Seven-Month High
Biotech company AC Immune said Thursday its Alzheimer's vaccine generated key antibodies in the brain, leading ACIU stock to pop. Shares hit a three-year high in premarket action. 
From Investor's Business Daily
Biogen Announces the Expiration Date Results of Its Cash Tender Offer
From GlobeNewswire News Releases
Biogen Announces the Expiration Date Results of Its Private Exchange Offer
From GlobeNewswire News Releases
Biogen and LabCentral Award Two Golden Tickets to Local and Innovative Science Startups
From GlobeNewswire News Releases
Biogen (BIIB) Shares Cross Above 200 DMA
In trading on Wednesday, shares of Biogen Inc (BIIB) crossed above their 200 day moving average of $274.67, changing hands as high as $277.25 per share. Biogen Inc shares are currently trading up about... 
Tags Stocks
From Market News Video
Biogen Announces the Pricing Terms of its Cash Tender Offer
From GlobeNewswire News Releases
Biogen Announces the Pricing Terms of Its Private Exchange Offer
From GlobeNewswire News Releases
Should You Sell Cassava Sciences Stock Now?
Can this company's Alzheimer's disease candidate deliver further gains ahead? 
Tags BIIB Market News SAVA
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.